Upper Extremity Rehabilitation With the BURT Robotic Arm

February 7, 2020 updated by: Paolo Bonato, Spaulding Rehabilitation Hospital

Upper Extremity Rehabilitation With the BURT Robotic Arm: a Feasibility Study

The overall objective of the proposed study is to carry out usability and design-evaluation assessments of the BURT robotic device for delivering long-term intervention in stroke survivors. The BURT is an upper extremity robotic device that enables the user to see and feel engaging games that encourage intensive therapy. The investigators intend to recruit up to 10 stroke survivors over the course of the study. Participants will train their arm with the BURT for 18 sessions over approximately 6 weeks then participate in a question/answer formatted discussion with research staff to discuss the usability of the device. The investigators will also assess participant's arm function at baseline and after the training sessions.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02129
        • Spaulding Rehabilitation Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male and female, age 18-80;
  • Having had a stroke (ischemic or hemorrhagic) at least 6 months prior to study
  • Moderate to severe upper-limb motor impairments (score of 15-45 out of 66 on the Fugl- Meyer Scale);
  • Community dwelling;
  • Able to physically fit in the device.

Exclusion Criteria:

  • Current participation in rehabilitation program targeting upper extremity function;
  • Cognitive impairment resulting to inability to follow instructions or inability to sustain attention for more than 10 minutes;
  • Visual impairments not corrected with lenses (visual loss);
  • Aphasia sufficient to limit comprehension and completion of the treatment protocol;
  • No more than moderate impairments in paretic UE sensation, passive range of motion, and pain that would limit ability to engage in therapy;
  • Increased muscle tone (passive movement is difficult);
  • Previous diagnosis of neurological diseases other than stroke;
  • Other conditions affecting function of the stroke affected upper limb;
  • Individuals who present with the following: open wounds, fragile skin, active infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm motor function retraining with BURT
All participants will receive 1 hour sessions, 2-3x/week for 6 weeks (total 18 sessions). Sessions will be organized with 30 minutes of robotic-assisted training and 30 minutes of hands-on training with a research therapist to work on the baseline goals of the subject. Hands-on training will be done with routinely employed techniques in therapy to transfer the skills gained with the robotic device in everyday life activities.
Intervention will be focused on patients impairments to assess the feasibility of the BURT device to carry-on long interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes From Baseline in Fugl-Meyer Upper Extremity Scores
Time Frame: 6 weeks
Assessment of upper extremity impairments. Individual items of the scale are summed for a total score ranking from 0 to 66. Higher scores indicate better outcomes.
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes From Baseline in Goal Attainment Scale Scores
Time Frame: 6 weeks

Standardized measure of goals selection and scaling to calculate the extend to which the participant's goals are met.

The Goal Attainment Scale ranges from -2 to +2. Positive scores indicates goals are better than expected, score of 0 indicates goals are met and negative scores indicates goals aren't met.

6 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes From Baseline in Wolf Motor Function Test Scores (Time Subscale)
Time Frame: 6 weeks
Assessment of upper-extremity function by the performance time of the Wolf Motor Function Test). The average of the 15 items is reported. The time ranges from 0 to 120 seconds. A decrease in performance time is associated with improved upper-extremity function.
6 weeks
Changes From Baseline in Motor Activity Log Scores
Time Frame: 6 weeks
Use of upper extremity in daily life. The self-reported amount of use is reported on a scale from 0 to 5. A score of zero is assigned when the hemiparetic side is not used during the activity of daily living, a score of 5 is assigned when the hemiparetic side is used as much as before the stroke. The 30 items of the scale are averaged. Higher scores are a sign of better use in daily life.
6 weeks
Changes From Baseline in Modified Ashworth Scale Scores
Time Frame: 6 weeks

Assessment of muscle tone for upper extremity muscles. Score rank from 0 (no tone) to 4 (no movement possible). Lower scores indicates a better outcome.

Tone at the shoulder and elbow were measured

6 weeks
Changes From Baseline in Articulations Range of Motion
Time Frame: 6 weeks
Assessment of active arm range of motion with goniometry. Results are reported in degrees and higher ranges include better outcomes.
6 weeks
Changes From Baseline in Manual Muscle Testing Scale Scores
Time Frame: 6 weeks
Assessment of arm muscle strength using the manual muscle testing scale ranking from 0 (no contraction) to 10 (maximal strength). Higher scores indicate better outcomes.
6 weeks
Changes From Baseline in Wolf Motor Function Test Scores (FAS Subcale)
Time Frame: 6 weeks

Assessment of upper-extremity function with the Functional ability subscale of the Wolf Motor Function Test.

The average of the 15 items is reported. Scores ranges from 0 to 5, they rate the quality of the movement performance. 0= do not attempt, up to 5= identical to contralateral side. Higher scores are associated with better movement quality.

6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 23, 2018

Primary Completion (Actual)

May 16, 2019

Study Completion (Actual)

May 16, 2019

Study Registration Dates

First Submitted

April 3, 2019

First Submitted That Met QC Criteria

May 23, 2019

First Posted (Actual)

May 29, 2019

Study Record Updates

Last Update Posted (Actual)

February 19, 2020

Last Update Submitted That Met QC Criteria

February 7, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2016P002590

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Arm motor function retraining with BURT

Subscribe